CicadaBio

Cicada Bio is a preclinical-stage biotechnology company dedicated to the development of circular RNA (circRNA) therapeutics. The company's proprietary platform focuses on engineering circRNA molecules that offer superior stability and more durable protein expression than conventional linear mRNA. By addressing the limitations of current RNA technologies, such as rapid degradation and the need for frequent dosing, Cicada Bio aims to transform the treatment landscape for genetic disorders, oncology, and chronic diseases. Headquartered in Menlo Park, California, the company is led by a team of experts in genome engineering and RNA biology. Cicada Bio is currently advancing its internal pipeline while building the foundational technology for the next generation of RNA-based medicines.